CANCER, a peer-reviewed journal of the American Cancer Society, shows that of all the recorded cases of breast cancer, at least 1% are Male Breast Cancer cases. Unfortunately, there hasn't been a randomized clinical trial until now to determine prognostic factors and treatment patterns.
Research conducted using the National Cancer Data Base (NCDB) shows that about 10,000 have been diagnosed with Male breast cancer(MBC), from 2004 to 2014. More than 70 percent of new cases of MBC are recorded by NCDB. That means there are 30 percent cases not recorded, adding to the additional cases of people who don't want to get treatment.
Also, research shows that close to 50% of patients, had Stage II disease hinting at a possible delay in seeking care. The higher the stage the worse the prognosis in lay terms. Factors associated with worse survival rates were older age, multiple comorbidities, black race, and high tumor grade and stage. People who live in higher-income areas; receiving appropriate chemotherapy, radiation, and anti-estrogen therapy as part of treatment had better survival.
"Our study highlights key differences between male and female breast cancers. Male Breast cancer is a separate disease entity and should be considered likewise" says Dr. Karam (@Dhauna_karam). Further, she believes that male breast cancer cases can be reduced and treated if there is more awareness about it. Like all cancer cases, early diagnosis is the key to getting a cure and escaping a serious medical condition that can result from MBC.
Abstract of the research is available via below link.
https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32472.
For more information or to obtain a PDF of full study, please contact:
Penny Smith +44 (0) 1243 770448 (UK)
[email protected]
Contact Info:
Name: Dhauna Karam MD
Email: Send Email
Organization: 4Isle Media
Website: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32472
Release ID: 88927565